Biomea Fusion, Inc.
BMEA
$2.16
$0.178.54%
| Weiss Ratings | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.93 | |||
| Price History | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -22.58% | |||
| 30-Day Total Return | -39.50% | |||
| 60-Day Total Return | -42.09% | |||
| 90-Day Total Return | -66.36% | |||
| Year to Date Total Return | -41.46% | |||
| 1-Year Total Return | -83.13% | |||
| 2-Year Total Return | -92.29% | |||
| 3-Year Total Return | -54.24% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -86.21% | |||
| 52-Week Low % Change | 2.58% | |||
| Price | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $14.43 | |||
| 52-Week Low Price | $1.94 | |||
| 52-Week Low Price (Date) | Apr 01, 2025 | |||
| 52-Week High Price (Date) | Apr 04, 2024 | |||
| Valuation | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 74.77M | |||
| Enterprise Value | 25.26M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.84 | |||
| Earnings Per Share Growth | 10.90% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.40 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.16 | |||
| Enterprise Value/EBITDA (TTM) | -0.18 | |||
| Enterprise Value/EBIT | -0.18 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 36.27M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 980 9099 | |||
| Address | 900 Middlefield Road Redwood City, CA 94063 | |||
| Website | biomeafusion.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -64.35% | |||
| Return on Equity | -- | |||
| Income Statement | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -142.32M | |||
| EBIT (TTM) | -144.07M | |||
| Net Income (TTM) | -138.43M | |||
| Net Income Avl. to Common (TTM) | -138.43M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 16.00% | |||
| EPS Diluted (TTM) | -3.84 | |||
| EPS Diluted Growth (Q YOY) | 17.15% | |||
| Balance Sheet | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 58.28M | |||
| Cash Per Share (Q) | $1.61 | |||
| Total Current Assets (Q) | 68.33M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 51.57M | |||
| Current Ratio (Q) | 3.153 | |||
| Book Value Per Share (Q) | $1.42 | |||
| Total Assets (Q) | 79.94M | |||
| Total Current Liabilities (Q) | 21.67M | |||
| Total Debt (Q) | 8.77M | |||
| Total Liabilities (Q) | 28.37M | |||
| Total Common Equity (Q) | 51.57M | |||
| Cash Flow | BMEA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -362.00K | |||
| Cash from Financing (TTM) | 1.67M | |||
| Net Change in Cash (TTM) | -118.59M | |||
| Levered Free Cash Flow (TTM) | -78.10M | |||
| Cash from Operations (TTM) | -119.89M | |||
